1Markus HS, Barley J, Lunt R, et al. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke, 1995, 26(8): 1329-1333.
2Chiang FT, Chern TH, Lai ZP, et al. Age and gender-dependent association of the angiotensin-converting enzyme gene with essential hypertension in a Chinese population. J Hum Hypertens, 1996, 10(12):823 -826.
3Rodriguez-Perez JC, Rodriguez-Esparragon F, Hernandez-Perera O, et al. Association of angiotensinogen M235T and A( - 6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene.J Am Coll Cardiol, 2001, 37(6): 1536-1542.
4McCarron MO, Niooll JA, Ironside JW, et al. Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors. Stroke, 1999, 30(8): 1643-1646.
5Peng DQ, Zhao SP, Wang JL. Lipoprotein(a) and apolipoprotein E epsilon 4 as independent risk factors for ischemic stroke. J Cardiovasc Risk, 1999, 6(1): 1-6.
6Aalto-Setala K, palomaki H, Miettinen H, et al. Genetic risk factors and ischaemio cerebrovascular disease: role of common variation of the genes encoding apolipoproteins and angiotensin-converting enzyme. Ann Med, 1998, 30(2): 224-233.
7Huang P, Kostulas K, Huang WX, et al. Lipoprotein lipase gene polymorphisms in ischaemic stroke and carotid stenosis. Eur J Clin Invest, 1997, 27(9): 740-742.
8Nishiuma S, Kario K, Yakushijin K, et al. Genetic variation in the promoter region of the beta-fibrinogene gene is associated with ischemic stroke in a Japanese population. Blood Coagul Fibrinolysis, 1998, 9(4):373-379.
9Carter AM, Catto AJ, Grant PJ. Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. Circulation, 1999, 99(18): 2423-2426.
10vander Put NM, van Straaten HW, Trijbels FJ, et al. Folate, homocysteine and neural tube defects: an overview. Exp Biol Med (Maywood),2001, 226(4): 243-270.
